The Evolution of Nonclinical Regulatory Science: Advanced Therapy Medicinal Products as a Paradigm
Henrik Tang Vestergaard(National Board of Health), Carla Herberts(Medicines Evaluation Board)
Cited by 24
Related Papers
Risk factors in the development of stem cell therapy
|Journal of Translational Medicine|2011|760